Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RIGL | Stock Option (Right to Buy) | Award | $0 | +37.5K | $0.00 | 37.5K | Nov 4, 2021 | Common Stock | 37.5K | $2.38 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On November 4, 2021, it was determined that the performance metric had been met. |
F2 | The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of October 25, 2021, subject to the reporting person's continuous service to the issuer through each such period. |